The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Adhezion Biomedical sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Adhezion is a medical device company that offers cyanoacrylate-based adhesive and infection prevention products. The company offers surgical solution, wound management and infection prevention solutions. It also develops and commercializes cyanoacrylate products for use in veterinary surgery. Adhezion also develops cyanoacrylate-based adhesives and sealants for use in the professional and consumer healthcare market. The company caters to acute and non-acute hospitals, surgery centers, and physician office-based markets. It operates through its various distribution partners across the US. Adhezion is headquartered in Wyomissing, Pennsylvania, the US.
The key metrics of Adhezion Biomedical related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Adhezion Biomedical is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Adhezion Biomedical.
For a detailed understanding of the performance of Adhezion Biomedical, buy the report here.